Clinical Study and Molecular Mechanism of Xuesaitong Soft Capsule in the Treatment of Acute Coronary Syndrome

NCT06618495 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Acute Coronary Syndrome

Interventions

DRUG: Xuesaitong soft capsule (main ingredient is Panax notoginseng saponins)

Sponsor

Xiyuan Hospital of China Academy of Chinese Medical Sciences